Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by SOUTHWELL DAVID P, Chief Executive Officer. Insider active across 3 companies, notably TScan Therapeutics, Inc.. Cumulatively, 16 filings have been recorded. Split: 2 buys · 0 sell. Total volume traded: €133k. Activity tracked since 8 September 2021. The latest transaction was filed on 18 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
11,000 shares@ US$8.73330.12% mcap21.2% of flowVoting Common StockSEC:0000899243-21-035442:0
Ideal exit: 5 Jun 2022 (T+270)
16 of 16 declarations
About SOUTHWELL DAVID P
David P. Southwell is the Chief Executive Officer and Board Member at TScan Therapeutics, Inc. and PTC Therapeutics, Inc. He is responsible for the strategic direction of these companies and managing daily operations. His role involves working closely with the board of directors to define the company's objectives and ensure its growth. Through his leadership, he contributes to the success of TScan and PTC.